ARCHIVES

FDA Revokes Avastin’s Accelerated Approval In Metastatic Breast Cancer Indication

This article is from The Cancer Letter archive.

Vol. 37 No. 43 | November 18, 2011

Download PDF Visit The Full Archive

Related Articles

Republican Congress To Shift Priorities, But Cancer May Get New Opportunities

November 18, 1994

P-32 Ingestion At NCI Attracts Attention; Similar Cases Seen At Labs In The Past

November 3, 1995

In Brief: Satcher Confirmed For U.S. Surgeon General; Bishop Selected As Chancellor Of UCSF

February 13, 1998

Nine Saturation Program Planning Contracts Approved

May 9, 1975

NCI-Approved Clinical Trials

January 26, 2007

NCI Puts $36 Million In Stimulus Funds Towards Early Clinical Trials

September 4, 2009